GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Jolly Pharmaceutical Co Ltd (SZSE:300181) » Definitions » Net Income Including Noncontrolling Interests

Zhejiang Jolly Pharmaceutical Co (SZSE:300181) Net Income Including Noncontrolling Interests : ¥555 Mil (TTM As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Zhejiang Jolly Pharmaceutical Co Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Zhejiang Jolly Pharmaceutical Co's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2025 was ¥183 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 was ¥555 Mil.


Zhejiang Jolly Pharmaceutical Co Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Zhejiang Jolly Pharmaceutical Co's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Jolly Pharmaceutical Co Net Income Including Noncontrolling Interests Chart

Zhejiang Jolly Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only 95.31 191.98 285.52 390.76 515.96

Zhejiang Jolly Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 144.11 155.74 127.53 88.58 183.39

Zhejiang Jolly Pharmaceutical Co Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥555 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Jolly Pharmaceutical Co Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Zhejiang Jolly Pharmaceutical Co's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Jolly Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No 388 Zhiyuan North Road, Moganshan Economic, Development Zone, Deqing, CHN, 313200
Zhejiang Jolly Pharmaceutical Co Ltd is a China-based company engaged in the production and distribution of pharmaceutical products. Its production lines include raw materials, tablets, capsules, particles and frozen dry powder injection. Its products include Wuling powder, Wuling capsule, linglianhua particle, clindamycin phosphate injection and other.
Executives
Shen Ai Ying Executives
Chen Guo Fen Executives
Yu You Qiang Director
Chen Jian Executives
Zheng Xue Gen Director
Guo Yin Li Supervisors
Wang Tao Executives
Yang Jun De Director
Chen Rui Xiang Supervisors
Dong Hong Yu Directors, executives
Zheng Chao Yi Directors, executives
Zhu Xiao Ping Executives
Wu Ying Securities Affairs Representative

Zhejiang Jolly Pharmaceutical Co Headlines

No Headlines